Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

103 recalls, newest first

Class II · Moderate risk

Adult Glycerin Suppositories

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

Terminated Microbial contamination US Pharmaceuticals Inc. NDC 0363-0441-00 D-1730-2019
Class II · Moderate risk

Adult Glycerin Suppositories

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

Terminated Microbial contamination US Pharmaceuticals Inc. NDC 0363-0441-50 D-1729-2019
Class II · Moderate risk

Adult Glycerin Suppositories

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

Terminated Microbial contamination US Pharmaceuticals Inc. NDC 0363-0445-25 D-1728-2019
Class II · Moderate risk

CVS Therapeutic Menthol Gel

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

Terminated Microbial contamination US Pharmaceuticals Inc. D-1726-2019
Class II · Moderate risk

CVS Health Glycerin Suppositories

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

Terminated Microbial contamination US Pharmaceuticals Inc. D-1724-2019
Class II · Moderate risk

Diphenhydramine HCL Liquid

Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination H J Harkins Company Inc dba Pharma Pac NDC 52959-0123-03 D-1430-2019
Class II · Moderate risk

Acetaminophen Children's Liquid

Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination H J Harkins Company Inc dba Pharma Pac NDC 52959-0309-04 D-1429-2019
Class II · Moderate risk

Robafen DM

CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Preferred Pharmaceuticals, Inc NDC 68788-0841-01 D-1410-2019
Class II · Moderate risk

Cetirizine Oral Solution 1 mg/mL

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination P & L Developments, LLC NDC 11673-178-04 D-1409-2019
Class II · Moderate risk

Cetirizine Oral Solution 1 mg/mL

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination P & L Developments, LLC NDC 63868-430-04 D-1408-2019
Class II · Moderate risk

Cetirizine HCL Oral Solution 1 mg/mL

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination P & L Developments, LLC NDC 55910-878-04 D-1407-2019
Class II · Moderate risk

Bisacodyl Suppositories

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1385-2019

Recalls by year